PTPRC and neoplasm: The flow analysis results are shown in Fig. 2H–L and Supplementary Fig. 6A-C, CD39i treatment induced a significant increase in immune cell infiltration in the tumor tissues, including CD45 + cells, CD4 + and CD8 + T cells.